FDA 483 Database
FDA Form 483s Issued in November 2022
Every published Form FDA 483 issued in November 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
6
Published 483s in November 2022
6
Distinct firms
Form 483s issued in November 2022
Fuji Yakuhin Co., Ltd.FDA
- FEI
- 3008538640
- Issued
- Nov 25, 2022
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- Japan
Chunghwa Chemical Synthesis & Biotech Co., Ltd.FDA
- FEI
- 3002806677
- Issued
- Nov 18, 2022
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- Taiwan
CareFirst Specialty Pharmacy LLCFDA
- FEI
- 3012258924
- Issued
- Nov 30, 2022
- Establishment
- Producer of Non Sterile Drug Products
- Location
- New Jersey, United States
Southern Tier Home Infusion, Inc. dba Pharmacy InnovationsFDA
- FEI
- 3004858203
- Issued
- Nov 30, 2022
- Establishment
- Producer of Sterile Drug Products
- Location
- Pennsylvania, United States
Lupin Limited Unit 1FDA
- FEI
- 3002807511
- Issued
- Nov 23, 2022
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- India
Aurobindo Pharma Unit 9FDA
- FEI
- 3006370489
- Issued
- Nov 18, 2022
- Establishment
- Drug Substance Intermediate Manufacturer
- Location
- India
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| Fuji Yakuhin Co., Ltd. | 3008538640 | Finished Pharmaceutical Manufacturer | Japan | Nov 25, 2022 | FDA |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3002806677 | Active Pharmaceutical Ingredient Manufacturer | Taiwan | Nov 18, 2022 | FDA |
| CareFirst Specialty Pharmacy LLC | 3012258924 | Producer of Non Sterile Drug Products | New Jersey, United States | Nov 30, 2022 | FDA |
| Southern Tier Home Infusion, Inc. dba Pharmacy Innovations | 3004858203 | Producer of Sterile Drug Products | Pennsylvania, United States | Nov 30, 2022 | FDA |
| Lupin Limited Unit 1 | 3002807511 | Finished Pharmaceutical Manufacturer | India | Nov 23, 2022 | FDA |
| Aurobindo Pharma Unit 9 | 3006370489 | Drug Substance Intermediate Manufacturer | India | Nov 18, 2022 | FDA |